Green methods for the simultaneous analysis of pharmaceutical mixtures present in disparate concentration ranges: Application to antidiabetic mixtures
暂无分享,去创建一个
[1] E. El-Kimary,et al. HPTLC Determination of Three Gliptins in Binary Mixtures with Metformin. , 2015, Journal of chromatographic science.
[2] E. Allen,et al. Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial , 2009, Diabetes, obesity & metabolism.
[3] H. I. Aljohar,et al. Stability-indicating capillary electrophoresis method for the simultaneous determination of metformin hydrochloride, saxagliptin hydrochloride, and dapagliflozin in pharmaceutical tablets , 2019, Journal of Liquid Chromatography & Related Technologies.
[4] Jacek Namieśnik,et al. Analytical eco-scale for assessing the greenness of analytical procedures , 2012 .
[5] A. Saad,et al. Simultaneous spectrophotometric determination of compounds having relatively disparate absorbance and concentration ranges; application to antidiabetic formulation of linagliptin and metformin. , 2018, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[6] G. Bray,et al. The metabolic syndrome : Epidemiology, Clinical Treatment, and Underlying mechanisms , 2008 .
[7] C. Kapnissi-Christodoulou,et al. Method Development by Use of Capillary Electrophoresis and Applications in Pharmaceutical, Biological and Natural Samples , 2012 .
[8] Won Chan Lee,et al. A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs loose-dose combination of oral anti-diabetes drugs , 2016, Journal of medical economics.
[9] J. Holst,et al. Dipeptidyl Peptidase‐4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP‐1 , 2010, Clinical pharmacology and therapeutics.
[10] B. Ayoub. UPLC simultaneous determination of empagliflozin, linagliptin and metformin , 2015 .
[11] J. Goldman-Levine. Combination Therapy When Metformin Is Not an Option for Type 2 Diabetes , 2015, The Annals of pharmacotherapy.
[12] J. Shubrook,et al. Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals , 2015, Postgraduate medicine.
[13] D. Matthews,et al. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[14] J. Shaw,et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.
[15] G. K. Mohan,et al. SIMULTANEOUS DETERMINATION OF METFORMIN, LINAGLIPTIN IN JENTADUETO AND METFORMIN, SAXAGLIPTIN IN KOMBIGLYZE BY LC-MS METHOD , 2018 .
[16] G. Schernthaner. Fixed‐dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care , 2010, Diabetic medicine : a journal of the British Diabetic Association.
[17] J. Płotka-Wasylka,et al. A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. , 2018, Talanta.